Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.
Therapeutic targeting of the beta-adrenergic receptors has recently shown remarkable efficacy in the treatment of benign vascular tumors such as infantile hemangiomas. As infantile hemangiomas are reported to express high levels of beta adrenergic receptors, we examined the expression of these recep...
Guardado en:
Autores principales: | Jessica M Stiles, Clarissa Amaya, Steven Rains, Dolores Diaz, Robert Pham, James Battiste, Jaime F Modiano, Victor Kokta, Laura E Boucheron, Dianne C Mitchell, Brad A Bryan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4b2b549a97aa468090e7e8cace6fc211 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Alpha and beta adrenergic receptors modulate keratinocyte migration.
por: Hsin-Ya Yang, et al.
Publicado: (2021) -
Therapy of Angiosarcoma with Thalidomide and Lenalidomide
por: M. Jules Mattes, et al.
Publicado: (2021) -
Clinical, dermoscopic and histopathologic findings of retiform hemangioendothelioma
por: Amanda Mota, et al.
Publicado: (2013) -
Thoracic composite hemangioendothelioma with neuroendocrine marker expression
por: Ei Miyamoto, et al.
Publicado: (2021) -
Pseudomyogenic Hemangioendothelioma Involving the Esophagus: A Case Report
por: Abdul-Rahman Fadi Diab, et al.
Publicado: (2021)